Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
(NASDAQ:QNTM),(CNSX:QNTM.CN),(Boerse Frankfurt – Freiverkehr:0K91),(CNSX:QNTM),(Boerse Frankfurt – Freiverkehr:0K91.F), TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma“), is pleased to announce that national television network CTV News' flagship investigative program W5 will air, starting today, a three-part series about Quantum Biopharma and the company's allegations of stock […]